Yes, this only relates to Dr Rose, which needs shareholder approval.
The announcement earlier today is a bit ambiguous.
Given this $1.5m needs approval, and is described as "additional', did the company just raise in effect $38.3 million (being $36.7m balance of placement and a further $1.5 m subject to approval)?
Or does "additional" relate to existing holdings of Dr Rose?
Suspect it is the former.
On the placements generally today, I would have liked to see some modest premium to reflect the FDA update, maybe 3 cents. Also, it would have been a great time to make participants confirm they had not sold shares since the FDA update (the selling in Aus seemed odd to me after the announcement).
But bigger picture, and particularly with Dr Rose, am very positive now.
Yes, this only relates to Dr Rose, which needs shareholder...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.57 |
Change
-0.210(11.8%) |
Mkt cap ! $1.792B | |||
| Open | High | Low | Value | Volume |
| $1.72 | $1.74 | $1.52 | $15.63M | 9.716M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5127 | $1.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.57 | 39613 | 3 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |